Florin-Andrei Taran
University of Tübingen
163 Papers
303 Citations
Florin-Andrei Taran is an academic researcher from University of Tübingen. The author has contributed to research in topics: Breast cancer & Medicine. The author has an hindex of 25, co-authored 139 publications. Previous affiliations of Florin-Andrei Taran include University of Zurich & Otto-von-Guericke University Magdeburg.
Chat about Author
Papers
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Andreas D. Hartkopf,Florin-Andrei Taran,Markus Wallwiener,Christina B. Walter,Bernhard K. Krämer,Eva-Maria Grischke,Sara Y. Brucker +6 more
TL;DR: This review summarizes the clinical efficacy, perspectives, and future challenges of using PD-1/PD-L1-directed antibodies in the treatment of breast cancer.
Early dissemination seeds metastasis in breast cancer
Hedayatollah Hosseini,Milan Obradovic,Martin Hoffmann,Kathryn Harper,Maria Soledad Sosa,Melanie Werner-Klein,Lahiri Kanth Nanduri,Christian Werno,Carolin Ehrl,Matthias Maneck,Nina Patwary,Gundula Haunschild,Miodrag Gužvić,Christian Reimelt,Michael Grauvogl,Norbert Eichner,Florian Weber,Andreas D. Hartkopf,Florin-Andrei Taran,Sara Y. Brucker,Tanja Fehm,Brigitte Rack,Stefan Buchholz,Rainer Spang,Gunter Meister,Julio A. Aguirre-Ghiso,Christoph Klein,Christoph Klein +27 more
TL;DR: It is shown that progesterone-induced signalling triggers migration of cancer cells from early lesions shortly after HER2 activation, but promotes proliferation in advanced primary tumour cells.
703
Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series
Stefan Kommoss,Melissa K. McConechy,Friedrich Kommoss,S Leung,Anne-Kathrin Bunz,Jamie Magrill,Heidi Britton,F Grevenkamp,Anthony N. Karnezis,Winnie Yang,Amy Lum,Bernhard K. Krämer,Florin-Andrei Taran,Annette Staebler,Sigurd Lax,Sara Y. Brucker,David G. Huntsman,C. B. Gilks,Jessica N. McAlpine,Aline Talhouk +19 more
TL;DR: A pragmatic molecular classification tool (ProMisE) that provides consistent categorization of tumors and identifies four distinct prognostic molecular subtypes and can be applied to diagnostic specimens enabling earlier informed decision-making is validated.
581
Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis.
François-Clément Bidard,Stefan Michiels,Sabine Riethdorf,Volkmar Mueller,Laura J. Esserman,Anthony Lucci,Bjørn Naume,Bjørn Naume,Jun Horiguchi,Rafael Gisbert-Criado,Stefan Sleijfer,Masakazu Toi,José A. García-Sáenz,Andreas D. Hartkopf,Daniele Generali,Françoise Rothé,Jeffrey B. Smerage,Laura Muinelo-Romay,Justin Stebbing,Patrice Viens,Mark Jesus M. Magbanua,Carolyn S. Hall,Olav Engebraaten,Daisuke Takata,Jose Vidal-Martinez,Wendy Onstenk,Noriyoshi Fujisawa,Eduardo Díaz-Rubio,Florin-Andrei Taran,Maria Rosa Cappelletti,Michail Ignatiadis,Charlotte Proudhon,Denise M. Wolf,Jessica B. Bowman Bauldry,Elin Borgen,Rin Nagaoka,Vicente Carañana,Jaco Kraan,M. Maestro,Sara Y. Brucker,Karsten Weber,Fabien Reyal,Dominic Amara,Mandar Karhade,Randi R. Mathiesen,Hideaki Tokiniwa,Antonio Llombart-Cussac,Alessandra Meddis,Paul Blanche,Koenraad d'Hollander,Paul Cottu,John W. Park,Sibylle Loibl,Aurélien Latouche,Jean-Yves Pierga,Klaus Pantel +55 more
TL;DR: Adding CTC detection before NCT increased the prognostic ability of multivariable prognostic models for overall survival, distant disease-free survival, and locoregional relapse-free interval and complements current prognosis models based on tumor characteristics and response to therapy.
The Diagnosis and Treatment of Ectopic Pregnancy.
Florin-Andrei Taran,Karl Oliver Kagan,M. Hübner,Markus Hoopmann,Diethelm Wallwiener,Sara Y. Brucker +5 more
TL;DR: Two randomized, controlled trials comparing organ-preserving treatment with ablative surgery revealed no significant difference in pregnancy rates after the intervention, but precise details of the surgical procedures were not provided, and long-term fertility data are lacking.